Streetbeat News

Products Services

KMT

Kennametal Inc. (NYSE: KMT) has announced its new FV Geometry, an innovative chipbreaker design that provides a stronger, sharper cutting edge for improved surface roughness and chip formation. The new design is expected to provide improved performance with consistent chip control at low or medium depths of cut and fewer process interruptions for tool changes.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:07 pm

LXRX

Lexicon Pharmaceuticals announced that INPEFA has received coverage from Express Scripts on its basic and high performance formularies for commercially insured patients.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:04 pm

NTDOY

WSM

Pottery Barn Teen, a division of Williams-Sonoma, Inc. (WSM), has announced a collaboration with the Super Mario franchise, owned by Nintendo Co., Ltd. (NTDOY). The exclusive collection of décor, textiles, and accessories inspired by the Mushroom Kingdom is now available at Pottery Barn Teen.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:58 pm

SAIC

Science Applications International Corp. (SAIC) has announced new data and AI features to improve government mission outcomes. The company is enhancing its AI and ML ecosystem by improving Tenjin and offering additional Koverse features.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:56 pm

YUM

Yum Brands has expanded its nuggets to Latin America and Caribbean markets in Q3 following a successful U.S. launch. The company reported an 'incredible consumer reception' that helped drive significant sales.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:45 pm

JAGX

Jaguar Health (NASDAQ:JAGX) has been granted a new U.S. patent for methods of treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, using crofelemer, a novel plant-based prescription drug. The company is supporting studies of crofelemer for SBS and microvillus inclusion disease (MVID) in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2023 and in 2024. Crofelemer has been granted Orphan Drug Designation (ODD) by the FDA and the European Medicines Agency for both MVID and SBS with intestinal failure.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:44 pm

CDXC

ChromaDex Corp. (NASDAQ:CDXC) has launched its clinical strength Tru Niagen® Pro 1,000mg, a Nicotinamide Adenine Dinucleotide (NAD+) booster, to consumers nationwide. The product is recommended by physicians and used by pro-athletes as it is clinically proven to boost NAD+ levels by up to 150% in as little as three weeks. The product is also Certified for Sport® by NSF International, a certification program recognized by the United States Anti-Doping Agency (USADA), Major League Baseball (MLB), and the National Hockey League (NHL).

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:42 pm

HSBC

RGTI

Rigetti UK Limited, a subsidiary of Rigetti Computing, Inc. (NASDAQ:RGTI), has been awarded an Innovate UK grant to enhance quantum machine learning methods for anti-money laundering detection. The consortium, which includes HSBC, the Quantum Software Lab at the University of Edinburgh, and the National Quantum Computing Centre, aims to improve current machine learning algorithms. The project, which began on September 1, 2023, will last 18 months.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:40 pm

NIO

NIO Inc's shares are trading higher after the company reported a 59.8% YoY increase in vehicle deliveries for October, with a total of 16,074 vehicles delivered. Year-to-date, the company has delivered 126,067 vehicles, a 36.3% YoY increase. Nio's ET5T model was also awarded a five-star safety rating by the European New Car Assessment Programme. Despite this, Nio's shares are down approximately 25% since the start of the year.

Portfolio Pulse from Adam Eckert

November 01, 2023 | 12:39 pm

NVO

Weight-loss drugs like Novo Nordisk's Ozempic and Wegovy are helping manage weight and diabetes. However, the same effect can be achieved by eating a high-fiber diet, according to Dr. Frank Duca of the University of Arizona’s Cancer Center. He suggests opting for whole foods rich in fermentable fiber, such as barley, oats, and rye.

Portfolio Pulse from Aaron Bry

November 01, 2023 | 12:36 pm